| |
| |
|
| Insider
Information: |
Cormorant Global Healthcare Master Fund, Lp |
| Relationship: |
|
| City: |
Boston |
| State: |
DC |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
8 |
|
| Direct
Shares |
3,473,925 |
|
|
Indirect Shares
|
17,939,179 |
|
|
| Direct
Value |
$141,076,094 |
|
|
|
Indirect Value
|
$201,397,635 |
|
|
| Total
Shares |
21,413,104 |
|
|
| Total
Value |
$342,473,730 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -2.6%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Cellectar Bioscienc |
CLRB |
10% Owner |
|
0 |
2014-08-15 |
530,000 |
Premium* |
|
|
Kineta Ord Shs |
KA |
10% Owner |
2016-11-03 |
0 |
2017-12-14 |
3,300,000 |
Premium* |
|
|
Apellis Pharmaceuticals Inc |
APLS |
10% Owner |
2017-11-13 |
3,473,925 |
2017-11-13 |
0 |
Premium* |
|
|
Kiniksa Pharmaceuticals, Ltd. |
KNSA |
10% Owner |
2018-05-29 |
0 |
2018-05-29 |
900,443 |
Premium* |
|
|
Kezar Life Sciences, Inc. |
KZR |
10% Owner |
2018-06-25 |
0 |
2018-06-25 |
1,572,909 |
Premium* |
|
|
Axonics Modulation Technologies,... |
AXNX |
10% Owner |
2018-10-31 |
0 |
2018-10-31 |
1,285,827 |
Premium* |
|
|
EyePoint Pharmaceuticals Inc |
EYPT |
|
2023-12-04 |
0 |
2024-05-06 |
8,325,000 |
Premium* |
|
|
Corbus Pharmaceuticals Holdings,... |
CRBP |
|
2024-03-07 |
0 |
2024-03-08 |
2,025,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
37 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CLRB |
Cellectar Bioscienc |
10% Owner |
– – • |
2014-08-15 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
530,000 |
|
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
10% Owner |
– – • |
2018-05-29 |
4 |
A |
$0.00 |
$0 |
I/I |
830,999 |
830,999 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
10% Owner |
– – • |
2018-05-29 |
4 |
B |
$18.00 |
$1,249,992 |
I/I |
69,444 |
900,443 |
1.5 |
- |
|
| AXNX |
Axonics Modulation Techno... |
10% Owner |
– – • |
2018-10-31 |
4 |
A |
$0.00 |
$0 |
I/I |
1,152,494 |
1,152,494 |
0 |
- |
|
| AXNX |
Axonics Modulation Techno... |
10% Owner |
– – • |
2018-10-31 |
4 |
B |
$15.00 |
$1,999,995 |
I/I |
133,333 |
1,285,827 |
1.5 |
- |
|
| KZR |
Kezar Life Sciences, Inc. |
10% Owner |
– – • |
2018-06-25 |
4 |
A |
$0.00 |
$0 |
I/I |
1,322,909 |
1,322,909 |
0 |
- |
|
| KZR |
Kezar Life Sciences, Inc. |
10% Owner |
– – • |
2018-06-25 |
4 |
B |
$15.00 |
$3,750,000 |
I/I |
250,000 |
1,572,909 |
1.5 |
- |
|
| CRBP |
Corbus Pharmaceuticals Ho... |
|
• • • |
2024-03-07 |
4 |
B |
$37.82 |
$10,013,367 |
I/I |
250,000 |
1,725,000 |
0.01 |
% |
|
| CRBP |
Corbus Pharmaceuticals Ho... |
|
• • • |
2024-03-08 |
4 |
B |
$41.23 |
$13,314,193 |
I/I |
300,000 |
2,025,000 |
0.01 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
10% Owner |
– – • |
2017-11-13 |
4 |
A |
$0.00 |
$0 |
D/D |
2,402,497 |
2,402,497 |
0 |
- |
|
| KA |
Kineta Ord Shs |
10% Owner |
– – • |
2016-11-03 |
4 |
B |
$7.24 |
$146,763 |
I/I |
20,277 |
2,450,882 |
1.5 |
- |
|
| KA |
Kineta Ord Shs |
10% Owner |
– – • |
2016-11-04 |
4 |
B |
$7.27 |
$612,901 |
I/I |
76,000 |
2,526,882 |
1.5 |
- |
|
| KA |
Kineta Ord Shs |
10% Owner |
– – • |
2016-11-07 |
4 |
B |
$8.69 |
$2,012,616 |
I/I |
231,700 |
2,758,582 |
1.5 |
- |
|
| KA |
Kineta Ord Shs |
10% Owner |
– – • |
2016-11-09 |
4 |
B |
$9.68 |
$117,121 |
I/I |
12,100 |
2,770,682 |
1.5 |
- |
|
| KA |
Kineta Ord Shs |
10% Owner |
– – • |
2016-11-10 |
4 |
B |
$11.07 |
$2,398,587 |
I/I |
216,700 |
2,987,382 |
1.5 |
- |
|
| KA |
Kineta Ord Shs |
10% Owner |
– – • |
2016-11-11 |
4 |
B |
$11.46 |
$242,975 |
I/I |
21,200 |
3,008,582 |
1.5 |
- |
|
| KA |
Kineta Ord Shs |
10% Owner |
– – • |
2016-11-14 |
4 |
B |
$11.48 |
$109,016 |
I/I |
9,500 |
3,018,082 |
1.5 |
- |
|
| KA |
Kineta Ord Shs |
10% Owner |
– – • |
2016-11-21 |
4 |
B |
$11.64 |
$1,302,622 |
I/I |
111,863 |
3,129,945 |
1.5 |
- |
|
| KA |
Kineta Ord Shs |
10% Owner |
– – • |
2016-11-22 |
4 |
B |
$11.08 |
$769,817 |
I/I |
69,500 |
3,199,445 |
1.5 |
- |
|
| KA |
Kineta Ord Shs |
10% Owner |
– – • |
2017-12-14 |
4 |
S |
$4.88 |
$2,461,164 |
I/I |
(504,027) |
3,300,000 |
0 |
- |
|
| KA |
Kineta Ord Shs |
10% Owner |
– – • |
2016-11-23 |
4 |
B |
$10.67 |
$2,052,506 |
I/I |
180,500 |
3,379,945 |
1.5 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
10% Owner |
– – • |
2017-11-13 |
4 |
B |
$14.00 |
$14,999,992 |
D/D |
1,071,428 |
3,473,925 |
2.45 |
- |
|
| KA |
Kineta Ord Shs |
10% Owner |
– – • |
2016-11-29 |
4 |
B |
$10.28 |
$1,319,523 |
I/I |
128,407 |
3,508,352 |
1.5 |
- |
|
| KA |
Kineta Ord Shs |
10% Owner |
– – • |
2016-12-01 |
4 |
B |
$10.11 |
$424,593 |
I/I |
41,984 |
3,550,336 |
1.5 |
- |
|
| KA |
Kineta Ord Shs |
10% Owner |
– – • |
2016-12-02 |
4 |
B |
$10.48 |
$523,800 |
I/I |
50,000 |
3,600,336 |
1.5 |
- |
|
37 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
